Saturday, May 21, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

The relative performance of OPS, NPS, and saliva for detecting the Delta and Omicron SARS-CoV-2 variants

by Medical Finance
in Coronavirus
Study: From Delta to Omicron SARS-CoV-2 variant: switch to saliva sampling for higher detection rate. Image Credit: Marmolejos/Shutterstock
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

Scientists have worked extensively hard to contain the coronavirus disease (COVID-19) pandemic caused by the rapid transmission of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). They developed diagnostic kits for rapid detection of the virus and developed many pharmaceutical and non-pharmaceutical means to reduce transmission of the virus as well as the mortality rate.

Study: From Delta to Omicron SARS-CoV-2 variant: switch to saliva sampling for higher detection rate. Image Credit: Marmolejos/Shutterstock
Study: From Delta to Omicron SARS-CoV-2 variant: switch to saliva sampling for higher detection rate. Image Credit: Marmolejos/Shutterstock

Background

At present, the standard detection technique for SARS-CoV-2 is the real-time polymerase chain reaction (RT-PCR) test using nasopharyngeal swab (NPS) samples. The collection of nasal samples is often an uncomfortable experience for patients. Scientists revealed that saliva- and oropharyngeal swab (OPS) sampling are less invasive methods. Another advantage of saliva sampling is that the sample can be self-collected and does not require trained healthcare persons equipped with protective measures.

Previous studies have revealed that OPS is less sensitive compared to NPS. However, a combination of NPS and OPS sampling provides better virus detection sensitivity compared to a single NPS sampling method. Previous studies have indicated that saliva could be an alternative sample for the PCR-based detection of the SARS-CoV-2 virus. Importantly, a recent study reported that in the case of the SARS-CoV-2 Omicron variant, saliva specimens exhibited higher sensitivity compared to NPS.

A new study

A new study published on medRxiv* preprint server has focused on evaluating the relative performance of OPS, NPS, and saliva for the Delta and Omicron SARS-CoV-2 variants. In this study, individuals who were present at the screening center in Ypres, Belgium, between December 3rd, 2021 and February 15th, 2022, for a SARS-CoV-2 RT-PCR test were asked to participate. The willing participants were provided with a questionnaire that contained questions about their eating, drinking, chewing, or smoking status 30 minutes prior to the Rt-PCR test.

In this study, nurses separately collected OPS and NPS samples, whereas saliva samples were collected in a CE-labeled sterile buffer-free container by spitting. To identify the SARS-CoV-2 variants that infected each participant, scientists performed SARS-CoV-2 whole-genome sequencing (WGS). Scientists included a total of 246 participants, among which 124 were male and 122 female, whose average age was 39 years. 155 participants were SARS-CoV-2 positive on at least one of the three sample types. 

Key findings

Researchers compared the Ct values of the three sample types considered in this study. They found higher statistically significant Ct values for OPS compared to NPS and saliva. This result strongly indicates lower sensitivity and negative prediction value (NPV) regardless of the type of SARS-CoV-2 variant.

Out of 155 SARS-CoV-2 positive samples, 152 samples were accurately detected for SARS-CoV-2 virus using both OPS and NPS samples. A marginal increase in sensitivity was observed when OPS and NPS samples were combined. To understand which sampling system is better for the detection of the SARS-CoV-2 variants, scientists compared the performance of NPS and saliva in both Delta and Omicron groups.

They observed a statistically significant lower Ct value for all tested genes in NPS samples, compared to saliva samples, for both Delta and Omicron variants. Additionally, detection of the Delta variant was comparable between NPS and saliva. Importantly, researchers found a higher sensitivity for the detection of SARS-CoV-2 Omicron variants using saliva samples compared to NPS. However, in the case of detection of the Delta variant, no statistically significant difference was found between NPS and saliva.

Interestingly, several samples (two Delta and ten Omicron infections) tested negative using NPS and tested positive on saliva samples. Researchers conducted follow-up testing among these candidates after two to four days and reported eleven patients to be positive for SARS-CoV-2. Among these eleven candidates, ten were SARS-CoV-2 positive on the NPS samples in addition to saliva specimens. Scientists performed logistic regressions and revealed that eating, drinking, chewing, or smoking, 30 minutes before the SARS-CoV-2 test had no impact on sensitivity for all three types of samples.

Conclusion

The authors of this study revealed that saliva samples are superior to NPS for detecting the SARS-CoV-2 Omicron variant. The current study further revealed that RT-PCR tests using saliva samples are more sensitive for the detection of the early phase of Omicron infection. The OPS sample is the least sensitive specimen for PCR-based detection of the SARS-CoV-2 virus compared to the NPS and saliva specimen.

*Important notice

medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

New report investigates how genomics could play a part in our lives in the future

Immune-boosting supplements do not lessen risk of death from COVID-19, review finds

by Medical Finance
May 21, 2022
0

A new review of COVID-19 hospitalization data by researchers at The University of Toledo has found that taking immune-boosting supplements...

Study: Co-infection with SARS-COV-2 Omicron and Delta Variants Revealed by Genomic Surveillance. Image Credit: G.Tbov/Shutterstock

First cases of co-infection with Delta and Omicron identified during local co-circulation of both SARS-CoV-2 lineages

by Medical Finance
May 21, 2022
0

In a recent study posted to the medRxiv* preprint server, researchers revealed the co-infection of the severe acute respiratory syndrome...

Study: Increased Potency and Breadth of SARS-CoV-2 Neutralizing Antibodies After a Third mRNA Vaccine Dose. Image Credit: Kateryna Kon/Shutterstock

Memory B cell repertoire in a longitudinal cohort of individuals receiving 3 COVID-19 mRNA vaccine doses

by Medical Finance
May 21, 2022
0

In a recent study posted to the bioRxiv* preprint server, a team of researchers examined the memory B cell repertoire...

Study: COVID-19 onset reduced the sex ratio at birth in South Africa. Image Credit: Paulo Vilela/Shutterstock

Reduction in the sex ratio at birth found following the COVID-19 pandemic

by Medical Finance
May 21, 2022
0

The sex ratio at birth (SRB) has been defined as male/(male+female) live births. SRB, at the population level in South...

Study: Assessment of 115 symptoms for Long COVID (post-COVID-19 condition) and their risk factors in non-hospitalised individuals: a retrospective matched cohort study in UK primary care. Image Credit: Ralf Liebhold/Shutterstock

Study determines 115 long COVID symptoms and their associated risk factors

by Medical Finance
May 21, 2022
0

Scientists have reported multisystem ailments associated with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, which is also the causal agent...

Study: Surveillance of Myopericarditis following COVID-19 Booster Dose Vaccination in a Large Integrated Health System. Image Credit: Lightspring/Shutterstock

Case ascertainment of myocarditis following COVID-19 booster vaccine

by Medical Finance
May 21, 2022
0

In a recent study posted to the medRxiv* preprint server, a team of researchers from the United States (US) performed...

Next Post
Study: Web and social media searches highlight menstrual irregularities as a global concern in COVID-19 vaccinations. Image Credit: 13_Phunkod / Shutterstock.com

The spread of menstrual irregularity and COVID-19 vaccines concerns on the web

Spice could play a key role in reducing salt intake among seniors

Spice could play a key role in reducing salt intake among seniors

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • shutterstock 369113957 e355e5336cc14dc19d0c66522344e34a 620x480
    Modular super-enhancer regulates gene expression involved in retina development
  • Study: Dynamics of Neutralizing Antibodies and Binding Antibodies to Domains of SARS-CoV-2 Spike Protein in COVID-19 Survivors. Image Credit: Kateryna Kon / Shutterstock.com
    Neutralizing antibody levels to different SARS-CoV-2 epitopes fluctuate over time
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply